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Flame retardants (FRs) are incorporated into
potentially ﬂammable materials such as plas-
tics, rubber, and textiles to slow down or
inhibit the initial phase of a developing fire.
Thus, FRs are important in modern society,
limiting the consequences of ﬁres and saving
lives. However, some FRs persist in the envi-
ronment (Hale et al. 2003; Law et al. 2003;
Norstrom et al. 2002) and bioaccumulate or
biomagnify. One class of these chemicals is
the polybrominated diphenyl ethers (PBDEs),
manufactured in different degrees of bromina-
tion, for example, pentaBDE, octaBDE, and
decaBDE. The lower brominated pentaBDE
product is primarily used in polyurethane
foam for upholstery applications, whereas the
mixtures with higher degrees of bromination
are used for applications such as housings for
electrical appliances.
PBDEs are a group of environmental
contaminants with a global distribution and
are present in wildlife species in both aquatic
(Hale et al. 2003; Kierkegaard et al. 1999) and
terrestrial (Norstrom et al. 2002; Sellström
1999) environments. However, concentrations
of PBDEs in humans and wildlife in North
America are much higher than concentrations
reported in Europe (Asplund et al. 1999;
Sjödin et al. 2003a).
Retrospective time-trend studies con-
ducted using environmental samples origi-
nating from the Swedish environment
showed a peak in environmental levels in the
mid-1980s, after which environmental con-
centrations decreased or remained unchanged
(Kierkegaard et al. 1999; Sellström 1999).
This trend has been shown for herring gull
eggs (Sellström 1999) originating from Stora
Karlsö, a small island in the Baltic Sea, and in
pike (Kierkegaard et al. 1999) collected in
Lake Bolmen in Sweden. These data indicate
that a potential lag exists between the time a
positive effect is observed in the environment
and the time a similar effect is noticeable in a
human population. Concentrations of the
lower brominated PBDEs in the Great Lakes
region in North America reportedly doubled
every 2.6–3.1 years from 1981 through 2000
(Norstrom et al. 2002). Considering the cur-
rent high use of the lower brominated PBDE
product (pentaBDE) in the United States,
this observation is not surprising.
The aim of the present inventory was to
determine the levels of PBDEs (n = 6),
2,2´,4,4´,5,5´-hexabromobiphenyl (BB-153),
and 2,2´,4,4´,5,5´-hexachlorobiphenyl
(CB-153) in archived serum samples col-
lected over 1985–2002 in order to assess the
concentration change over time in serum for
the target analytes. The occurrence of bromi-
nated ﬂame retardants (BFRs) was to be com-
pared with that of the stable and persistent
polychlorinated biphenyl (PCB) congener
CB-153.
Methods and Materials
Serum samples. Archived serum pools used as
quality assurance/quality control (QA/QC)
pools in the measurement of organohalogen
compounds and/or serum lipids were used in
the present study. Serum pools (n = 36) from
1985–1997 and 2002 were collected in the
southeastern United States by the Interstate
Blood Bank (Memphis, TN). Serum samples
from 1999–2002 were collected in Seattle,
Washington, by Solomon Park Research
Laboratories (Kirkland, WA). Serum pools
(n = 16) were prepared according to the
principles and methods that formed the basis
for the National Committee for Clinical
Laboratory Standards guidelines (NCCLS
1999). Additionally, for this study the serum
lipid concentration of the serum pools was
determined using commercially available test
kits from Roche Diagnostics Corporation
(Indianapolis, IN) for the quantitative deter-
mination of total triglycerides (product no.
011002803-0600) and total cholesterol
(product no. 011573303-0600). Final deter-
minations were made on a Hitachi 912
Chemistry Analyzer (Hitachi, Tokyo, Japan).
The number of donors in the serum pools
from the southeastern United States ranged
from 40 to 200, and serum from six to eight
blood donors was used to make the pools
originating from Seattle. Because of the lower
number of blood donors in the pools originat-
ing from Seattle, the average for each year is
included in Table 1 and used for all statistical
handling of the data.
All serum samples were collected by con-
venient sampling and hence may not be con-
sidered representative of the general U.S.
population. The project was exempt for
human subjects review because the serum
specimens were pooled and no personal iden-
tifying information was collected.
A mixture of calf serum (0.5 mL; Gibco
BRL, Grand Island, NY) and water (3.5 mL)
was used as method blanks.
Certified reference standards. We used
two internal standard spiking solutions from
Cambridge Isotope Laboratories (Andover,
MA) for the BFRs and PCBs. The spiking
standard for BFRs contained the following
13C12-labeled congeners at a concentration
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Research Articleof 7.5 pg/µL in methanol: 2,2,4´-tribromo-
diphenyl ether (BDE-28); 2,2´,4,4´-
tetraBDE (BDE-47); 2,2´,4,4´,5-pentaBDE
(BDE-99); 2,2´,4,4´,6-pentaBDE (BDE-
100); 2,2´,4,4´,5,5´-hexaBDE (BDE-153);
2,2´,4,4´,5,6´-hexaBDE (BDE-154);
2,2´,3,4,4´,5´,6-heptaBDE (BDE-183);
decaBDE (BDE-209); and BB-153. The
spiking standard for PCBs contained 13C12-
CB-153 at a concentration of 7.5 pg/µL in
methanol. The recovery spiking standard was
also obtained from Cambridge Isotope
Laboratories and contained the labeled com-
pounds 1,2,3,4-tetrachlorodibenzo-p-dioxin
(13C6-1,2,3,4-TCDD, 2.5 pg/µL); 3,3´,4,4´-
tetraBDE (13C12-BDE-77, 7.5 pg/µL);
2,2´,3,4,4´,6-hexaBDE (13C12-BDE-139,
7.5 pg/µL); and 2,2´,3,3´,4,5,5´,6,6´-
nonachlorinated biphenyl (13C12-CB-208,
10 pg/µL). The solvent for the recovery stan-
dard was n-hexane containing 10% and 2% by
volume of nonane and dodecane, respectively.
We used a 10-point calibration curve span-
ning the concentration range 0.2–2,000 pg/µL
containing the 13C12-labeled BFRs and
13C12-CB-153 at a concentration of 75 pg/µL
for the gas chromatography/isotope dilu-
tion high-resolution mass spectrometry
(GC-IDHRMS) analyses. The calibration
curve contained the following native ana-
lytes: 2,2´,4-triBDE (BDE-17); BDE-28;
BDE-47; 2,3´,4,4´-tetraBDE (BDE-66);
2,2´,3,4,4´-pentaBDE (BDE-85); BDE-99;
BDE-100; BDE-153; BDE-154; BDE-183:
2,2´,3,4,4´,5,5´,6-octaBDE (BDE-203);
BDE-209; BB-153; and CB-153.
Chemicals. Reagents and solvents used in
the present study were of the highest grade
available and/or intended for pesticide residue
analysis and were used only after veriﬁcation by
GC-IDHRMS analysis monitoring for the
BFRs listed above. Dichloromethane (DCM),
n-hexane, and methanol were of pesticide grade
and purchased from TEDIA (Fairﬁeld, OH),
HPLC-grade water also was purchased from
TEDIA. Hydrochloric acid (37% in water
99.999%) was purchased from Aldrich
(Milwaukee, WI). Formic acid (minimum
88%, ACS grade) was purchased from EM
Science, an affiliate of Merck (Darmstadt,
Germany). n-Nonane (< 99%) and silica gel
(63–200 µm) were purchased from Sigma
(St. Louis, MO).
Solid-phase extraction (SPE) cartridges
packed with OASIS HLB sorbent (540 mg)
were obtained from Waters Corporation
(Milford, MA). Custom-made SPE cartridges
containing activated silica (0.1 g; top layer)
and silica:sulfuric acid 2:1 by weight (1 g;
bottom layer) were obtained from Applied
Separations (Allentown, PA).
Cleaning of glassware and other consum-
ables. Before use, all glassware was cleaned in a
dishwasher Steam Scrubber (Labconco, Kansas
City, MO) and heated overnight in a Thelco
laboratory oven (Precision, Winchester, VA) at
250°C. Pasteur pipettes were not washed in the
dishwasher but were heated directly in the
same oven overnight. Teﬂon-lined screw caps
and Teﬂon-lined silicone septa were sonicated
in methanol and air dried before use.
Instrumentation. Addition of internal
standards, denaturation of the sample using
formic acid, and dilution of the sample with
water before extraction were automated with a
215 Liquid Handler (Gilson, Middleton, WI)
ﬁtted with a 402-syringe pump (Gilson). The
syringe pump was equipped with a 250-µL
syringe as well as a 10-mL syringe (Gilson).
The syringe pump was connected via 10.5-mL
coiled-transfer tubing to a septum-piercing
probe. A methanol bottle was connected to
the syringe pump to purge the transfer tubing
and rinse the septum-piercing probe (Gilson)
used for drawing and dispensing standard
solutions and reagents. Samples were mixed by
rotation using an 818 AutoMix (Gilson). This
instrumentation was controlled and operated
with UniPoint (version 5.5) software (Gilson).
SPE and cleanup were automated using the
Rapid Trace SPE workstation (Zymark,
Hopkinton, MA). This modular SPE system
was controlled and operated using Rapid Trace
workstation software (version 1.20; Zymark).
A Rapid Vap (Labconco, Kansas City,
MO) was used for sample evaporation
employing vortex action, vacuum, and an ele-
vated temperature to aid the evaporation
process.
IDHRMS analysis was performed on a
MAT95XP instrument (ThermoFinnigan
MAT; Bremen, Germany). The chromato-
graphic separations were carried out using a
6890N gas chromatograph (Agilent, Atlanta,
GA) fitted with a DB5HT capillary column
(15 m, 0.25 mm inner diameter, 0.10 µm
ﬁlm thickness; Agilent). Splitless injection was
carried out with an injector temperature of
280°C; the oven was programmed from
140°C (1 min) to 320°C (1.5 min) with a
ramp rate of 10°C/min. The source tempera-
ture was 280°C in the electron impact mode
using a ﬁlament bias of 40 eV.
Sample preparation. The analytical
method used for sample extraction and
cleanup has been recently published (Sjödin
et al. 2003b, in press). Brieﬂy, the serum sam-
ples were processed in batches of 30 including
method blanks [n = 3; containing calf serum
(0.5 mL) and water (3.5 mL)] and QA/QC
samples (n = 3; human serum). Serum samples
(4 g) were weighed into 16 × 100 mm test
tubes fitted with Teflon-lined silicone septa.
The samples were transferred to the Liquid
Handler for automatic fortification with
13C12-labeled internal standards. In the same
procedure, the samples also were pretreated
with formic acid (4 mL) and diluted with
water (4 mL), before SPE. The extractions
were carried out in an automated procedure
overnight on a modular SPE workstation. In
this procedure, the samples were loaded onto
an SPE cartridge containing 540 mg OASIS
HLB sorbent at a flow rate of 0.4 mL/min
after conditioning of the sorbent with
methanol, DCM, and 0.1 M hydrochloric
acid in 5% aqueous methanol solution. After
complete loading of the sample, the cartridge
was dried with pressurized nitrogen at a pres-
sure of 140 kPa for 40 min. Final elution of
the sample from the sorbent was made by
DCM (12 mL) at a flow rate of 1 mL/min.
The ﬁnal extract was then evaporated to dry-
ness in the vacuum evaporator.
Coextracted lipids were removed during
an automated cleanup procedure on the SPE
workstation. The cleanup cartridge comprised
two layers packed into a 3-mL SPE cartridge.
The top layer in the cartridge was activated
silica (0.1 g activated at 250°C, overnight),
and the bottom was a mixture of silica and
concentrated sulfuric acid (2:1 by weight).
The dry sample extracts were loaded into
racks for the automated SPE cleanup, which
involved reconstitution of the samples with
hexane (1 mL) and loading onto the cleanup
cartridge. This procedure was repeated with
two more 1-mL volumes of hexane to ensure
complete reconstitution of the samples. Final
elution of the target analytes was achieved
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Table 1. Concentration [median (range) ng/g lipid] of selected BFRs and CB-153 in archived serum pools
from the United States, stratiﬁed according to 5-year collection periods.
1985–1989 (n = 9) 1990–1994 (n = 14) 1995–1999 (n = 10) 2000–2002 (n = 7)
Compound Median (range) Median (range) Median (range) Median (range)
PBDEs
BDE-47 5.4 (< 1–44) 28 (3.7–49) 46 (24–68) 34 (29–98)
BDE-85 < 0.5 (< 0.5–1.08) 0.61 (0.50–1.4) 0.78 (0.50–1.9) 0.70 (0.50–1.4)
BDE-99 < 2 (< 2–15) 10 (1.3–18) 13 (9.1–29) 11 (6.8–26)
BDE-100 0.81 (< 0.5–7.3) 4.0 (0.63–7.7) 6.7 (3.8–14) 5.9 (3.5–18)
BDE-153 0.84 (< 0.5–7.3) 1.6 (0.67–15) 4.2 (2.5–16) 7.3 (1.8–17)
BDE-154 < 0.5 ( < 0.5–0.94) < 0.5 (< 0.5–1.07) 0.88 (0.52–1.8) 0.95 (0.50–1.8)
ΣPBDE 9.6 (4.6–74) 48 (7.5–86) 71 (42–120) 61 (47–160)
PBBs
BB-153 8.0 (2.6–9.4) 5.3 (1.0–8.6) 4.7 (1.9–10) 3.3 (1.4–5.5)
PCBs
CB-153 90 (48–140) 66 (38–87) 52 (36–110) 35 (19–49)with an additional 8 mL hexane. The sample
extracts were then evaporated to 0.5 mL and
quantitatively transferred to GC vials that had
been fortified with recovery standards. The
samples were finally evaporated to approxi-
mately 10 µL in the GC vials using the vacuum
evaporator.
Final analytical measurements of target
analytes were performed using GC-IDHRMS,
as described above and by Sjödin et al.
(2003b, in press). All concentration data
reported are background corrected for average
amount of analyte detected in blank samples
(n =3   per 24 unknowns). The limit of detec-
tion when contaminants were detectable in
blank samples was deﬁned as three times the
standard deviation of the blank samples. A
signal-to-noise (S:N) ratio of 10 was used to
define the instrumental limit of detection
when no contaminants were detectable in the
blank samples.
Calculation of population half-lives. The
observed decay half-lives for CB-153 and
BB-153 were estimated for the population by
using a single compartment model with ﬁrst-
order kinetics (Yang and Andersen 1994).
The relationship between chemical concentra-
tion (C) and time (t) of sampling with first-
order kinetics is expressed in Equation 1,
where kel represents the decay rate or the
elimination rate constant:
Ct = C0e-kelt [1]
The terminal log-linear phase of elimination
in this model was used to determine the half-
life (t1/2) using Equation 2. The elimination
rate constant (kel) is defined by Equation 3,
where C and t represent the chemical concen-
tration and the time at which the specimen
was collected, respectively.
[2]
[3]
Results
We determined six PBDEs (tetraBDE to
hexaBDE), BB-153, and CB-153 in human
serum pools collected during 1985–2002. The
median and range of concentrations in these
pools with respect to the BFRs and CB-153
are shown in Table 1, stratiﬁed according to
5-year collection periods. Time of sample col-
lection is plotted against concentration data
for BDE-47, the sum of PBDEs (ΣPBDEs),
BB-153, and CB-153 in Figure 1.
Correlation coefﬁcients for the individual
target analytes and the ΣPBDEs versus the
time of sample collection are shown in
Table 2.
The concentrations determined for all
PBDEs with the exception of BDE-85
increased signiﬁcantly during the study period,
with BDE-47 being the dominating congener.
The median level of BDE-47 increased from
5.4 ng/g lipid in 1985–1989 to 34 ng/g
lipid for 2000–2002 (Table 1). In contrast,
decreasing levels were observed for BB-153
and CB-153 throughout the study period.
The summary parameters for the linear
regression analysis of the logarithmic chemical
concentration versus time for CB-153 and
BB-153 in 40 samples are presented in Table 3.
For CB-153, the observed decay rate was
determined to be 0.065/year, and the observed
decay half-life was 11 years. For BB-153, the
observed decay rate was 0.058/year, and the
decay half-life was 12 years.
Discussion
Concentrations of PBDEs are well known to
have been increasing in Europe from studies
conducted in Sweden (Meironyté et al. 1999;
Meironyté Guvenius 2002), Norway (Thomsen
et al. 2002), and Germany (Schröter-Kermani
et al. 2000). More recently, similar findings
have been reported for Japan (Akutsu et al.
2003). However, during recent years a decrease
in concentration has been indicated in Sweden,
probably because of a decrease in use of the
lower brominated PBDEs in Europe, as shown
by recent use figures [Bromine Science and
Environmental Forum (BSEF) 2003].
Estimated use of the pentaBDE mixture in
Europe was 150 metric tons/year in 2001. Use
of the same product in North America was
estimated at 7,100 metric tons in 2001, corre-
sponding to 95% of the total world demand
for this product (BSEF 2003).
Information about current and historic
concentrations of PBDEs in humans is lacking
or limited for North America. However, a
recent review in which previously published
concentration data on PBDEs were used to
construct a time trend, we (Sjödin et al.
2003a) reported increasing levels of PBDEs in
North America. The average concentration of
BDE-47 in earlier studies was 0.63 ng/g lipid
(range, < 0.4–24; n = 12) in serum in 1988
(Illinois; Sjödin et al. 2002); 33 ng/g lipid in
breast adipose tissue (range, 7–200; n = 23) in
the late 1990s (California Bay, California; She
et al. 2002); 83 ng/g lipid (n = 19) in a milk
pool in 1997 (New York; Betts 2002);
130 ng/g lipid in a milk pool in 2000 (Austin,
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Figure 1. Linear regression trends for concentrations (ng/g lipid) of (A) BDE-47, (B) the ΣPBDEs,
(C)C B-153, and (D) BB-153 in serum pools plotted against the year of sample collection. 
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Table 2. Spearman’s rank order correlation coefﬁ-
cients and p-levels for the correlation of the meas-
ured organohalogen compounds in the United
States versus collection year (1985–2002).
Compound Rp -Value
PBDEs
2,2´,4,4´-TetraBDE (BDE-47) 0.61 < 0.01*
2,2´,3,4,4´-PentaBDE (BDE-85) 0.22 0.18
2,2´,4,4´,5-PentaBDE (BDE-99) 0.59 < 0.01*
2,2´,4,4,6-PentaBDE (BDE-100) 0.57 < 0.01*
2,2´,4,4´,5,5´-HexaBDE (BDE-153) 0.61 < 0.01*
2,2´,4,4´,5,6-HexaBDE (BDE-154) 0.34 < 0.05
ΣPBDEs 0.55 < 0.01*
PCBs
2,2´,4,4´,5,5´-HexaCB (CB-153) –0.70 < 0.01*
PBBs
2,2´,4,4´,5,5´-HexaBB (BB-153) –0.51 < 0.01*
*Statistically signiﬁcant at p < 0.05.
Table 3. Regression of the logarithm of CB-153 and
BB-153 on time in 40 samples.
Coefﬁcient SE p-Value
CB-153
Intercept 58 8.2 < 0.001
Time –0.028 0.0041 < 0.001
BB-153
Intercept 51 13 < 0.001
Time –0.025 0.0068 < 0.001TX, and Denver, CO; Päpke et al. 2001); and
41 ng/g lipid in milk in 2001 (range, 2.9–270;
n = 47) (Texas; Schecter 2003). These concen-
trations compare favorably with those gener-
ated in the present study (Table 1). Similarly,
the concentrations of the tetraBDEs through
hexaBDEs in the U.S. serum pools are signiﬁ-
cantly increasing over time (Table 2).
Furthermore, PBDE levels are substantially
higher than those reported for European sam-
ples. BDE-47 levels in current (1997–2000)
human milk from Sweden range from 1.7 to
2.3 ng/g lipid (Meironyté et al. 1999;
Meironyté Guvenius 2002). In people with a
high dietary intake of ﬁsh from the Baltic Sea
(12–20 meals/month) in Sweden, the median
PBDE level was 2.2 ng/g lipid (range,
0.96–5.7) for samples collected in 1991
(Sjödin et al. 2000). This can be compared
with 0.4 ng/g lipid (< 0.1–2.5) for Swedish
people with a negligible consumption of ﬁsh
(Sjödin et al. 2000). Baltic Sea ﬁsh is considered
to be a high-risk food with respect to exposure
to organohalogen compounds such as PCBs.
These studies reveal that Americans who have a
median concentration of 34 ng/g lipids (range,
29–98; during 1990–2002) of BDE-47 in their
blood were exposed at a much higher degree to
lower brominated PBDEs than people in
Europe. The exact exposure pathways have not
been elucidated; however, they may be similar
to other persistent environmental contaminants
such as PCBs (Sjödin et al. 2000); that is, the
diet may be the major pathway of exposure. On
the other hand, direct exposures such as inhala-
tion and/or dermal exposure (Sjödin et al.
1999, 2001) cannot be excluded for chemicals
still being used and may have a substantial con-
tribution to the exposures observed.
The serum from which the pools were
made was collected by sampling at blood banks
and is not representative of the general U.S.
population. An important factor to consider in
this regard is the large size of our sampling
region, covering the southeastern United States
and Seattle, Washington. Limited information
was available to us about the location where
the blood bank collected the samples from
which we made the pools. This lack of infor-
mation prevented us from addressing geo-
graphical differences and their effects on the
time trend. However, there appears to be
increased variability in the concentrations in
the pools based on the 2000–2002 pools for
BDE-47 from the southeastern United States
(n = 4, mean ± SD, 35 ± 7.7 ng/g lipid) and
Seattle (n = 3, mean ± SD, 57 ± 35). However,
we can conclude that the variability in the con-
centrations in the pools is large; for example,
for both areas combined, the mean ± SD of the
BDE-47 concentration (n = 7) was 44 ±
24 ng/g lipids for 2000–2002. One plausible
reason for the observed variability may be
geographic differences including differences
in the diet and lifestyle as well as sex.
However, in an earlier Swedish study (Sjödin
et al. 2000), no correlation between age of the
individuals and PBDE body burden was
observed. This may be because PBDEs are
currently being used in industry and expo-
sures to the general population have been
increasing over time, resulting in similar life-
time exposures independent of the individ-
ual’s age (Sjödin et al. 2000). Further, the use
of pooled samples prevented us from assessing
variability individuals including potential
effects from the individual’s age and/or sex.
In addition to the PBDEs, we measured
CB-153 and BB-153 in all the samples.
CB-153 is the major PCB congener found in
most environmental and human matrices and
indicates the total PCB level (Grimvall et al.
1997). We made no attempt to determine the
total PCB concentration in our study. BB-153
is the main constituent of technical hexabro-
mobiphenyl (hexaBB). HexaBB has been used
and applied as an FR. Although it was banned
after an accident in Michigan in the 1970s in
which cattle feed was contaminated by this
technical product, commercial production of
the BB product continued in Europe. To the
best of our knowledge, polybrominated
biphenyls (PBBs) are no longer commercially
produced worldwide.
We found a significant decreasing trend
for BB-153 and CB-153 (Table 2, Figure 1).
This trend verifies that the levels for these
environmental contaminants have been
decreasing since the ban of their use in the
mid-1970s. The levels of BB-153 are lower
than for the main PBDE congener BDE-47,
except for 1985–1989 (Table 1). However, in
recent years the levels of BDE-47 are compa-
rable or higher than the levels of CB-153 in
the serum samples analyzed (Table 1). The
highest concentration of CB-153 in the study
was close to 140 ng/g lipid weight for a sam-
ple collected in 1985. The median concentra-
tion for BDE-47 for 2000–2002 was 34 ng/g
lipid (range, 29–98 ng/g lipid). 
Blanck et al. (2000) estimated the half-life
of BB-153 to be in the range of 13–29 years in
humans exposed to BB-153 in a dairy feed
accident in Michigan in 1973, where animal
feeds were accidentally contaminated with
PBBs. The half-life of CB-153 in humans
occupationally exposed to PCBs has been esti-
mated to be 4–30 years (Ryan et al. 1993;
Yakushiji et al. 1984). In another study using
a population occupationally exposed to
PBDEs, the half-lives of BDE-153 (hexaBDE),
BDE-183 (heptaBDE), and BDE-209
(decaBDE) have been estimated to be 680,
110, and 14 days, respectively (Jakobsson
et al. 2003). The half-lives in humans for the
lower brominated PBDEs (tetraBDEs
through pentaBDEs) may be longer because
an increase in half-life was observed with
decreasing bromination degree for decaBDE,
octaBDE, and hexaBDE (Jakobsson et al.
2003); however, this has not yet been demon-
strated. In our study, a single-compartment
model with first-order kinetics was used to
estimate the observed populational half-lives
for CB-153 and BB-153. This model is sup-
ported by the linear response obtained from
the study (Table 3) and when individual
human data are used (Blanck et al. 2000;
Ryan et al. 1993). Also, animal experiments
with PCBs (Clarke et al. 1984; Wyss et al.
1986) and PBB (Fries and Marrow 1978)
demonstrated a similar process for elimina-
tion. We estimated the populational half-life
to be about 11 and 12 years for CB-153 and
BB-153, respectively. These estimates com-
pare favorably with earlier findings (Blanck
et al. 2000; Ryan et al. 1993; Yakushiji et al.
1984). However, our estimates of the decay
half-lives represent not only the elimination
of these chemicals from the population but
also the population’s continuous decrease in
exposure to these chemicals over time. Hence,
our results are estimates of the population’s
half-life and not that of the individuals.
The brominated diphenyl ethers are major
environmental contaminants in the U.S. gen-
eral population and represent a health concern
based on animal toxicity data. PBDEs cause
neurodevelopmental effects in mice dosed
with relatively high concentrations of BDE-47
and BDE-99 (Eriksson et al. 2001, 2002;
Viberg et al. 2002). Further research is needed
to assess whether any adverse effects on
human health may be related to the PBDEs at
the concentrations reported in this study.
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